about
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients ...
Read More
4.73
0.38
(8.74%)
187.2K
XNAS Volume
XNAS 14 Jul, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Cingulate Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..